Scienza e Tecnologia
Alkermes to Report First Quarter Financial Results on May 1, 2024
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in
Dublin, Ireland , Alkermes has a research and development center in
Waltham, Massachusetts ; a research and manufacturing facility in Athlone,
Ireland ; and a manufacturing facility in
Wilmington, Ohio . For more information, please visit Alkermes' website at www.alkermes.com.
Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402
Logo - https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/alkermes-to-report-first-quarter-financial-results-on-may-1-2024-302119896.html